Home Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx
 

Keywords :   


Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx

2016-02-03 03:52:40| drugdiscoveryonline News Articles

DiscoveRx Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announced today the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays

Tags: development cancer drugs accelerate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
More »